Approval · Notice of Compliance 27861 · 2022
RALIVIA: Notice of Compliance 27861
Issued March 31, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27861
- Date
- March 31, 2022
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph and updates to the labels as per the Advisement Letter.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RALIVIA | Not yet assigned | — |
Medicinal ingredients
- TRAMADOL HCL 100 MG per TAB
- TRAMADOL HCL 200 MG per TAB
- TRAMADOL HCL 300 MG per TAB